VCJ Staff

Nayatek Raises First Round

Nayatek, a Newark, Del.-based provider of enterprise information management solutions, has raised an undisclosed amount of Series A funding led by Originate Ventures.

Solar Cell Repower Raises Series A

Solar Cell Repower, a Norwegian company focused on improving the efficiency of solar cells, has raised NOK 10 million ($1.48m) in Series A funding from return backer NorthZone Ventures. It also has secured another NOK 12 million in grants and loans from Innovation Norway.

Clear2Pay Raises €6 Million

Clear2Pay, a Brussels-based provider of payment solutions for financial institutions, has raised €6 million in VC funding from return backers AGF Management, IRIS Capital, Big Bang Ventures, GIMV and Trust Capital.

Taptu Raises £6.45 Million

Taptu, a Cambridge, UK-based pure-play mobile search engine, has raised £6.45 million in Series B funding from return backers 3i Group and Sofinnova investments.

Prosensa Raises €18 Million

Prosensa BV, a Dutch developer of RNA-based therapeutics, has raised €18 million in Series B funding. GIMV and AGF Management co-led the round, and were joined by return backers Abingworth Management, Life Sciences Partners and MedSciences Capital. www.prosensa.eu

Cornerstone Pharma Raises $6 Million

Cornerstone Pharmaceuticals Inc., a drug development company focused on cancer bioenergetics, has raised $6 million in new angel funding. It has offices in both Stony Brook, N.Y. and Cranbury, New Jersey.

ProspX Raises $6.5 Million

ProspX Inc., an Austin, Texas-based provider of collaboration and automation applications for the commercial insurance industry, has raised $6.5 million in Series A funding led by Adams Capital Management.

Wyeth Buys Thiakis Ltd.

Wyeth Pharmaceuticals, a unit of Wyeth (NYSE: WYE), has acquired Thiakis Ltd., a UK-based developer of peptide hormones for the treatment of obesity. The deal includes a $30 million up-front payment, and up to $120 million in possible earn-outs. Thiakis raised a £10 million Series A round in 2006 from Novo AS, Advent Venture Partners, The Royal Society, Esperante, Consensus Business Group, NPI Ventures and Imperial Innovations.

BioTrove Cancels IPO

Mavenir Systems Adds $17.5 Million